➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Moodys
AstraZeneca
Express Scripts
Johnson and Johnson
Dow

Last Updated: July 4, 2020

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR MEBENDAZOLE

» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Mebendazole

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00116493 Severe Anemia Treatment Trials, Pakistan Completed Aga Khan University Phase 3 2004-04-01 The purpose of this study is to test the efficacy of two enhanced regimens (deworming and multivitamins) in the treatment of severe anemia in pregnant women and children 6-24 months of age in Karachi, Pakistan.
NCT00116493 Severe Anemia Treatment Trials, Pakistan Completed Johns Hopkins Bloomberg School of Public Health Phase 3 2004-04-01 The purpose of this study is to test the efficacy of two enhanced regimens (deworming and multivitamins) in the treatment of severe anemia in pregnant women and children 6-24 months of age in Karachi, Pakistan.
NCT01050452 Safety and Efficacy of Drug Combinations Against Trichuris Trichiura Completed DBL -Institute for Health Research and Development N/A 2007-10-01 This randomised, controlled, double-blinded clinical study investigates the safety and efficacy of albendazole (ALB), mebendazole (MBD) and ivermectin (IVM) separately, and ALB and MBD each in combination with IVM in the treatment of Trichuris trichiura in children aged 5-14 years.
NCT01173562 A Safety Study of Mebendazole in Children 2 to 10 Years of Age Completed Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Phase 3 2010-02-01 The purpose of this study is to assess the safety and tolerability of mebendazole 500-mg chewable tablet formulation in a pediatric population. Mebendazole is a drug used for the treatment of soil-transmitted parasitic helminth (STH) (ie, parasitic worm) infections such as pinworm, whipworm, common roundworm, common hookworm, and American hookworm.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Mebendazole

Condition Name

Condition Name for Mebendazole
Intervention Trials
Helminthiasis 3
Hookworm Infections 2
Anaplastic Astrocytoma 2
Anemia 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Mebendazole
Intervention Trials
Infection 6
Helminthiasis 6
Communicable Diseases 5
Hookworm Infections 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Mebendazole

Trials by Country

Trials by Country for Mebendazole
Location Trials
Tanzania 4
Ethiopia 3
United States 3
Egypt 2
Uganda 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Mebendazole
Location Trials
Maryland 2
New York 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Mebendazole

Clinical Trial Phase

Clinical Trial Phase for Mebendazole
Clinical Trial Phase Trials
Phase 4 10
Phase 3 6
Phase 2 2
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Mebendazole
Clinical Trial Phase Trials
Completed 14
Recruiting 7
Not yet recruiting 4
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Mebendazole

Sponsor Name

Sponsor Name for Mebendazole
Sponsor Trials
Swiss Tropical & Public Health Institute 3
Bill and Melinda Gates Foundation 3
University Ghent 3
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Mebendazole
Sponsor Trials
Other 64
Industry 7
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Mallinckrodt
Moodys
Merck
McKinsey
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.